PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: barber

COVID-19: In Vitro Diagnostic Testing - Cigna

Page 1 of 24 Medical Coverage Policy: 0557 Medical Coverage Policy Effective Date ..10/15/2021 Next Review Date .. 1/15/2022 Coverage Policy Number .. 0557 COVID-19: In Vitro Diagnostic Testing Table of Contents Overview .. 1 Coverage Policy .. 1 General Background .. 3 Medicare Coverage Determinations .. 19 Coding/Billing Information .. 20 References .. 22 Related Coverage Resources COVID-19 Drug/Biologic Therapeutics Anti-Stockpiling Limits INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies.

A molecular or antigen in vitro diagnostic test for SARS-CoV-2 (COVID-19) infection is considered diagnostic and is a covered service with no …

Tags:

  Diagnostics

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of COVID-19: In Vitro Diagnostic Testing - Cigna

Related search queries